Lyphochek Coagulation Control, Level 4, Model 743

FDA 510(k) K032611 · Bio-Rad

Substantially Equivalent

510(k) numberK032611

Submission

Device name
Lyphochek Coagulation Control, Level 4, Model 743
Applicant
Bio-Rad
Irvine, CA, US
Received
August 25, 2003
Decision date
September 17, 2003
Decision
Substantially Equivalent (SESE)
Type
Special 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
GGN – Plasma, Coagulation Control
Device class
Class II (moderate risk)
Regulation
21 CFR 864.5425
Specialty
Hematology

Other 510(k)s with product code GGN

510(k)DeviceApplicantDecision
K170864VALIDATE D-Dimer Calibration Verification / Linearity Test KitGGN · Traditional Maine Standards Company, LLC06/21/2017SE
K163498VALIDATE Heparin Calibration Verification/Linearity Test KitGGN · Traditional Maine Standards Company, LLC03/16/2017SE
K161316George King Coumadin PlasmaGGN · Traditional George King Bio-Medical, Inc.02/23/2017SE
K162705VALIDATE® D-Dimer Calibration Verification/ Linearity Test KitGGN · Traditional Maine Standards Company, LLC01/05/2017SE
K152961VALIDATE D-Dimer Calibration Verification/Linearity Test KitGGN · Traditional Maine Standards Company, LLC06/03/2016SE
K150144VisuCon-F Low Fibrinogen Control PlasmaGGN · Traditional Affinity Biologicals, Inc.03/06/2016SE
K142132Pool NormGGN · Traditional Diagnostics Stago S.A.S.12/12/2014SE
K133582Hemosil D-Dimer HS 500 ControlGGN · Traditional Instrumentation Laboratory08/15/2014SE
K120977Directcheck Control for Hemochron Jr. Microcoagulation Systems Act-Lr Cuvette…GGN · Traditional International Technidyne Corp.07/03/2013SE
K120900I-Stat PT Control Leviel 1 I-Stat PT Control Level 2GGN · Traditional Cliniqa Corporation05/31/2013SE

More from Cliniqa Corporation

510(k)DeviceDecision
K171061MRSASelect IIJSO · Traditional 12/28/2017SE
K122187Vreselect Culture MediumJSO · Traditional 11/06/2012SE
K103684Vreselect Culture MediumJSO · Traditional 10/21/2011SE
K093678Platelia Aspergillus Eia Model 62793NOM · Traditional 01/13/2011SE
K100589Mrsa Select - Skin and Soft Tissue Wound SpecimensJSO · Traditional 10/29/2010SE
K081362Platelia Lyme IgmLSR · Traditional 06/26/2008SE
K081212Mrsaselect - Extended IncubationJSO · Traditional 06/13/2008SE
K080012Platelia Lyme Igg AssayLSR · Traditional 05/08/2008SE
K070361MrsaselectJSO · Traditional 09/13/2007SE
K060641Platelia Aspergillus Eia, Model 62793NOM · Traditional 06/02/2006SE

Questions and answers

When was Lyphochek Coagulation Control, Level 4, Model 743 cleared by the FDA?

Lyphochek Coagulation Control, Level 4, Model 743 (K032611) received a 510(k) decision of Substantially Equivalent on September 17, 2003, 23 days after the submission was received.

What is the product code of K032611?

The FDA product code is GGN – Plasma, Coagulation Control, a Class II (moderate risk) device regulated under 21 CFR 864.5425.